Cargando…
Transient and DNA‐free in vivo CRISPR/Cas9 genome editing for flexible modeling of endometrial carcinogenesis
Autores principales: | Navaridas, Raúl, Vidal‐Sabanés, Maria, Ruiz‐Mitjana, Anna, Perramon‐Güell, Aida, Megino‐Luque, Cristina, Llobet‐Navas, David, Matias‐Guiu, Xavier, Egea, Joaquim, Encinas, Mario, Bardia, Lídia, Colombelli, Julien, Dolcet, Xavier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174088/ https://www.ncbi.nlm.nih.gov/pubmed/36762520 http://dx.doi.org/10.1002/cac2.12409 |
Ejemplares similares
-
In Vivo Intra‐Uterine Delivery of TAT‐Fused Cre Recombinase and CRISPR/Cas9 Editing System in Mice Unveil Histopathology of Pten/p53‐Deficient Endometrial Cancers
por: Navaridas, Raúl, et al.
Publicado: (2023) -
Lack of extracellular matrix switches TGF-β induced apoptosis of endometrial cells to epithelial to mesenchymal transition
por: Ruiz-Mitjana, Anna, et al.
Publicado: (2022) -
Endometrial PTEN Deficiency Leads to SMAD2/3 Nuclear Translocation
por: Eritja, Núria, et al.
Publicado: (2021) -
ARID1A‐deficient cells require HDAC6 for progression of endometrial carcinoma
por: Megino‐Luque, Cristina, et al.
Publicado: (2022) -
Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancer
por: Eritja, Núria, et al.
Publicado: (2017)